Resmed Inc. Stock
Price
Target price
€189.60
€189.60
10.880%
18.6
10.880%
€189.13
14:13 / Tradegate
WKN: 895878 / Symbol: RMD / Name: ResMed / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Resmed Inc. Stock
A very strong showing by Resmed Inc. today, with an increase of €18.60 (10.880%) compared to yesterday's price.
Resmed Inc. is currently one of the favorites of our community with 16 Buy predictions and no Sell predictions.
However, we have a potential of -0.32% for Resmed Inc. as the target price of 189 € is below the current price of 189.6 €.
Pros and Cons of Resmed Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
B****
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Resmed Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Resmed Inc. | 10.880% | 2.457% | -4.094% | -17.231% | 9.091% | -1.327% | 94.672% |
| QuidelOrtho Corp. | -3.660% | 2.778% | -15.487% | -54.668% | -45.444% | -61.410% | - |
| Boston Scientific | 1.460% | 7.874% | 10.341% | 46.933% | 33.165% | 93.996% | 108.049% |
| Illumina Inc. | -0.390% | 2.883% | -8.872% | -43.384% | -12.233% | -67.110% | -60.601% |
Comments
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Needham & Company LLC from $215.00 to $224.00. They now have a "buy" rating on the stock.
Show more
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $215.00 price target on the stock.
Show more
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $227.00 price target on the stock.
Show more
Ratings data for RMD provided by MarketBeat
News
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank
For both the biotech and pharmaceutical industries, what happens in the laboratory is critical to success (or failure, on the flip side).
Some good news from a clinical trial conducted by Eli Lilly
Why ResMed Stock Is Jumping Today
Shares of ResMed (NYSE: RMD) were jumping 7% as of 11:25 a.m. ET on Thursday after rising as much as 10.6% earlier in the morning. The solid gain came after the medical device maker announced
2 Monster Stocks to Buy Without Any Hesitation
While the phrase "monster stocks" might generally have investors thinking of Tesla, Apple, or similar behemoths, the two businesses discussed in this article are sneakily monstrous.
First, consumer